Advances in PET/CT Technology

The last 12 months have seen significant growth in the positron emission tomography/computed tomography (PET/CT) segment of radiology, from both a manufacturing and a research perspective. One brand-new system received U.S. Food and Drug Administration (FDA) market clearance just months ago, while another started making its way into hospitals in the second half of last year. Several manufacturers also released software updates to help integrate PET/CT imaging into radiation therapy planning and execution. The increased interest was supported by several large studies exploring the advanced applications of PET/CT in oncology imaging.
CTA, CT, contrast media injector, contrast injector, EmpowerCTA

The biggest trend in contrast media injector technology today is one seen throughout all of healthcare — doing more with less, or maximizing the utility of existing technology. In the case of contrast media, vendors are focusing on systems that make full use of the existing contrast supply in an effort to reduce contrast dose. This shift is happening with contrast media across multiple modalities. Vendors are also allowing injector systems to integrate with electronic medical records (EMR), picture archiving and communication systems (PACS) and other technology to automatically record and analyze contrast dose data.

There were many examples of clinical decision support (CDS) software currently on the market that could be leveraged to address Stage 3 Meaningful Use on the expo floor of the Healthcare Information and Management Systems Society (HIMSS) 2016. During HIMSS, Ascendian Healthcare Consulting CEO Shawn McKenzie sat down with itnTV and discussed how and why CDS should be integrated into the radiology workflow. 

Physicians at University Hospitals Seidman Cancer Center (Cleveland) have started a clinical trial using a new form of stereotactic body radiotherapy (SBRT) to deliver radiation to a specific area of a cancerous prostate instead of the entire gland.

April 28, 2016 — The American Society for Radiation Oncology (ASTRO) and radiation oncologists nationwide hailed the introduction of federal legislation that would drive alternative payment models, protect patients and reduce Medicare costs. The legislation would accomplish this by closing a costly loophole in the physician self-referral law.

Konica Minolta introduced the latest version of the Sonimage HS1 compact ultrasound system, enabling improved image quality, streamlined workflow and new cardiac functionality for the point-of-care ultrasound market.

Alliance Oncology, a division of Alliance HealthCare Services Inc., announced that one of their radiation therapy centers, Reno CyberKnife, has upgraded their CyberKnife Robotic Radiosurgery System.

Breast cancer patients undergoing treatment with trastuzumab-containing regimens should be monitored for heart damage regardless of age.

Journees Francophones de Radiologie Diagnostique & Interventionnelle 2016

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now